From March 2014-March 2015, I worked with an international consortium of non-governmental organizations, academics, governments, and independent consultants to oppose attempts to place ketamine, an essential medicine, under strict international controls that would have drastically limited its use as a human and veterinary anesthetic in low-income countries. As part of this project, I attended the United Nations’ Commission on Narcotic Drugs in Vienna, Austria, twice, met with and lobbied member states, worked with relevant non-governmental organizations, and conducted several interviews with international media outlets. Because of this on-the-ground health policy advocacy, we were successful in defeating attempts to place ketamine under international controls. This project led to two publications in the prestigious medical journal The Lancet.